Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 3/20 | 0.49 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.49 |
| ▸ | LMNA | P02545 | 4/20 | 0.44 |
| ▸ | PRKCA | P17252 | 5/20 | 0.44 |
| ▸ | PRKCE | Q02156 | 2/20 | 0.44 |
| ▸ | PRKCQ | Q04759 | 2/20 | 0.44 |
| ▸ | PRKCD | Q05655 | 2/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | DGKA | P23743 | 1/20 | 0.40 |
| ▸ | FAAH | O00519 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | CNR1 | P21554 | 1/20 | 0.39 |
| ▸ | CNR2 | P34972 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1899724 | 1.00 | MAPT (0.49) | MAPTMAPK1LMNAPRKCAPRKCE | |
| SCHEMBL5355667 | 1.00 | MAPT (0.49) | MAPTMAPK1LMNAPRKCAPRKCE | |
| SCHEMBL789885 | 0.94 | PRKCA (0.51) | MAPTMAPK1PRKCAPRKCEPRKCQ | |
| SCHEMBL8179685 | 0.92 | MAPT (0.51) | MAPTMAPK1LMNAPRKCAPRKCE | |
| SCHEMBL11506064 | 0.92 | MAPT (0.51) | MAPTMAPK1LMNAPRKCAPRKCE | |
| SCHEMBL8201074 | 0.92 | MAPT (0.51) | MAPTMAPK1LMNAPRKCAPRKCE | |
| SCHEMBL2129639 | 0.90 | MAPT (0.49) | MAPTMAPK1LMNAPRKCAPRKCE | |
| SCHEMBL1534016 | 0.89 | MAPT (0.48) | MAPTMAPK1LMNAPRKCAPRKCE | |
| SCHEMBL9225414 | 0.85 | MAPT (0.53) | MAPTMAPK1LMNAPRKCAPRKCE | |
| SCHEMBL9227207 | 0.85 | MAPT (0.53) | MAPTMAPK1LMNAPRKCAPRKCE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090208437-A1 | GLYCOPYRROLATE IN COSMETIC PREPARATIONS | BEIERSDORF AG (DE) | 2009-08-20 | — | — | US | claimed |
| EP-1048292-B1 | Stable combination of active agents containing surface-active gucose derivatives and salicylic acid | BEIERSDORF AG (DE) | 2007-12-12 | — | — | EP | claimed |
| EP-1013262-B1 | Cosmetic and dermatologic o/w-emulsions containing boron nitride | BEIERSDORF AG (DE) | 2006-11-29 | — | — | EP | claimed |
| EP-1393707-B1 | Cosmetic composition for cleaning and care of the skin | BEIERSDORF AG (DE) | 2006-05-31 | — | — | EP | claimed |
| US-6911210-B1 | Stable active ingredient combinations which are effective against blemished skin and against acne and contain interface-active glucose derivatives and hydroxycarbolic acids | BEIERSDORF AG (DE) | 2005-06-28 | — | — | US | claimed |
| US-20250228901-A1 | COMPOSITION FOR PREVENTING, ALLEVIATING OR TREATING INFLAMMATORY SKIN DISEASES, COMPRISING CUTIBACTERIUM SP. STRAIN | CJ BIOSCIENCE, INC. (KR) | 2025-07-17 | — | — | US | disclosed |
| US-20250049699-A1 | COSMETIC COMPOSITION FOR PREVENTION OR IMPROVEMENT OF INFLAMMATORY SKIN DISEASES COMPRISING STRAIN OF GENUS CUTIBACTERIUM | CJ BIOSCIENCE, INC. (KR) | 2025-02-13 | — | — | US | disclosed |
| EP-4424299-A1 | COSMETIC COMPOSITION FOR PREVENTION OR IMPROVEMENT OF INFLAMMATORY SKIN DISEASES COMPRISING STRAIN OF GENUS CUTIBACTERIUM | CJ Bioscience, Inc. (KR) | 2024-09-04 | — | — | EP | disclosed |
| EP-4424318-A1 | COMPOSITION FOR PREVENTING, ALLEVIATING OR TREATING INFLAMMATORY SKIN DISEASES, COMPRISING CUTIBACTERIUM SP. STRAIN | CJ Bioscience, Inc. (KR) | 2024-09-04 | — | — | EP | disclosed |
| CN-111479547-B | Oil-in-water cosmetic composition with high-content calamine stabilized in inner phase | 株式会社爱茉莉太平洋 | 2023-03-28 | — | — | CN | disclosed |
| EP-2560666-A1 | ACTIVE INGREDIENT COMBINATIONS OF MAGNOLIA BARK EXTRACT AND SURFACE-ACTIVE AGENTS (POLYGLYCERYL-3 METHYLGLUCOSE DISTEARATE) | Beiersdorf AG (DE) | 2013-02-27 | — | — | EP | disclosed |
| US-8343467-B2 | Glycopyrrolate in cosmetic preparations | BEIERSDORF AG (DE) | 2013-01-01 | — | — | US | disclosed |
| US-20040223931-A1 | Exfoliated phyllosilicate-based cosmetic compositions | L'OREAL (FR) | 2004-11-11 | — | — | US | disclosed |
| US-20020192178-A1 | Leguminous extract heavy-metal-scavenging anti-pollution agent | L'OREAL (FR) | 2002-12-19 | — | — | US | disclosed |
| US-6432391-B1 | FOR APPLICATION TO COSMETIC SUBSTRATES CHOSEN FROM HUMAN SKIN, KERATINOUS SUBSTANCES, SCALPS, AND LIPS, AND WHICH COMPRISES A LIQUID FATTY PHASE GELLED BY A FATTY POLYAMIDE | L'ORéAL S.A. (FR) | 2002-08-13 | — | — | US | disclosed |
| US-20020044918-A1 | Transparent scented solid cosmetic composition | L'OREAL S.A. (FR) | 2002-04-18 | — | — | US | disclosed |
| US-6372199-B1 | Use of unsymmetrically substituted triazine derivatives in cosmetic or dermatological preparations for maintaining the urocanic acid status of the skin | BEIERSDORF AG (DE) | 2002-04-16 | — | — | US | disclosed |
| US-6174520-B1 | UVA photoprotective cosmetic/dermatological compositions comprising iron chelating agents | SOCIETE L'OREAL S.A. (FR) | 2001-01-16 | — | — | US | disclosed |
| US-6106850-A | LIGHT PROTECTIVE COSMETIC/DERMATOLOGICAL COMPOSITION WITH KETONE SULFONIC ACID COMPOSITION | SOCIETE L'OREAL S.A. (FR) | 2000-08-22 | — | — | US | disclosed |
| US-5776472-A | TOPICAL COSMETIC | SOCIETE L'OREAL S.A. (FR) | 1998-07-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090208437-A1 | GLYCOPYRROLATE IN COSMETIC PREPARATIONS | GYPA, TPO, DDT | MAPT 3786/4885MAPK1 4223/4885LMNA 4791/4885 |
| US-20020044918-A1 | Transparent scented solid cosmetic composition | CUTA, FASN, ACADM | MAPT 924/4885MAPK1 4434/4885LMNA 2640/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.